We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+11.26%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.59B
AUM Growth
+$121M
(+8.2%)
Cap. Flow
-$3.78M
Cap. Flow
% of AUM
-0.24%
Top 10 Holdings %
Top 10 Hldgs %
42.51%
Holding
54
New
11
Increased
10
Reduced
8
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$58.6M |
| 2 |
UnitedHealth
UNH
|
+$48.9M |
| 3 |
Zoetis
ZTS
|
+$45.1M |
| 4 |
Post Holdings
POST
|
+$36.6M |
| 5 |
LNW
Light & Wonder
LNW
|
+$28.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TRNX
TORNIER N V SHARES (NLD)
TRNX
|
+$64.7M |
| 2 |
AGN
Allergan Inc
AGN
|
+$50.2M |
| 3 |
JetBlue
JBLU
|
+$33.4M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$29.7M |
| 5 |
TRLA
TRULIA INC (DEL)
TRLA
|
+$28.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.96% |
| 2 | Consumer Discretionary | 14.37% |
| 3 | Financials | 10.83% |
| 4 | Communication Services | 6.91% |
| 5 | Technology | 5.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
TG Therapeutics
TGTX
$8.01B
| $28.2M | 1.78% |
1,780,538
-1,814,083
| -50% | -$23.6M |
|
27
Centene
CNC
$30.6B
| $26.9M | 1.69% |
1,035,488
+433,304
| +72% | +$10.1M |
|
|
SHPG
28
DELISTED
Shire pic
SHPG
| $26.4M | 1.66% |
+124,250
| New | +$26.4M |
|
29
Tenet Healthcare
THC
$20.5B
| $25.8M | 1.62% |
509,320
-301,916
| -37% | -$15.8M |
|
30
Humana
HUM
$44.1B
| $25.1M | 1.58% |
+174,890
| New | +$23.9M |
|
|
WMGI
31
DELISTED
Wright Medical Group Inc
WMGI
| $20M | 1.26% |
744,272
-184,992
| -20% | -$5.41M |
|
|
AVNS
32
DELISTED
Avanos Medical
AVNS
| $18.8M | 1.18% |
+413,662
| New | +$16.3M |
|
|
P
33
DELISTED
Pandora Media Inc
P
| $18.2M | 1.14% |
1,019,726
+304,364
| +43% | +$6.02M |
|
34
CALL
Alerian MLP ETF
AMLP
$13B
| $17.5M | 1.1% |
+200,000
| New | +$18.1M |
|
35
Arrowhead Research
ARWR
$12B
| $17.4M | 1.09% |
+2,354,878
| New | +$16M |
|
|
CMRX
36
DELISTED
Chimerix, Inc.
CMRX
| $15.9M | 1% |
+395,712
| New | +$13.4M |
|
37
Cardiff Oncology
CRDF
$65.9M
| $9.21M | 0.58% |
29,762
| – | – |
|
38
Atara Biotherapeutics
ATRA
$74.4M
| $6.51M | 0.41% |
+9,738
| New | +$5.95M |
|
39
Cameco
CCJ
$37.8B
| $3.93M | 0.25% |
239,306
| – | – |
|
40
Casella Waste Systems
CWST
$5.65B
| $2.25M | 0.14% |
555,933
| – | – |
|
|
RGDX
41
DELISTED
RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
| $1.9M | 0.12% |
6,000,000
| – | – |
|
42
Agios Pharmaceuticals
AGIO
$1.87B
| – | – |
-220,099
| Closed | -$13.5M |
|
43
Bruker
BRKR
$9.54B
| – | – |
-770,414
| Closed | -$14.3M |
|
|
44
JetBlue
JBLU
$2.29B
| – | – |
-3,148,170
| Closed | -$33.4M |
|
45
Regeneron Pharmaceuticals
REGN
$77.6B
| – | – |
-16,218
| Closed | -$5.85M |
|
46
Vipshop
VIPS
$7.33B
| – | – |
-1,289,160
| Closed | -$24.4M |
|
47
Zillow
ZG
$7.93B
| – | – |
-194,058
| Closed | -$7.5M |
|
|
MNK
48
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
-329,627
| Closed | -$29.7M |
|
|
SODA
49
DELISTED
SodaStream International Ltd
SODA
| – | – |
-130,000
| Closed | -$3.83M |
|
|
AMRI
50
DELISTED
Albany Molecular Research Inc
AMRI
| – | – |
-813,934
| Closed | -$18M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q4 2014 Portfolio in Review
As of Q4 2014, Bridger Management held 54 positions worth $1.59B, up 8.2% from $1.47B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Bridger Management's Q4 2014 filing shows 11 new, 10 increased, 8 reduced and 13 closed positions. Its largest new stake was Allergan plc: 234,562 shares worth $60.4M. The largest sale was TORNIER N V SHARES (NLD), an estimated $64.7M.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 41% a quarter earlier, followed by Consumer Discretionary and Financials.
- Bridger Management's largest Q4 2014 buy was Allergan plc: 234,562 shares worth $60.4M.
- Bridger Management added most to Light & Wonder in Q4 2014, an estimated $28.9M increase.
- Bridger Management's biggest Q4 2014 reduction was TG Therapeutics, cutting an estimated $23.6M.
- Bridger Management fully exited TORNIER N V SHARES (NLD) in Q4 2014, selling an estimated $64.7M.
- Bridger Management's ten largest holdings make up 43% of its $1.59B portfolio in Q4 2014.
- Bridger Management opened 11 new positions and closed 13 in Q4 2014.
- Bridger Management's portfolio value rose 8.2% quarter-over-quarter to $1.59B.
Based on Bridger Management's 13F filing for Q4 2014, filed 17 Feb 2015.